Lawsuit Filed Against Infuse Bone Graft Manufacturer
LOUISVILLE, KY - The Courier-Journal reported this week that a lawsuit has been filed against Medtronic and Norton Hospital in Kentucky, after a Louisville woman was reportedly permanently disabled from a bone graft procedure in 2006. According to the newspaper report, plaintiff Crystal Stevens suffered "substantial nerve damage" and must recline or lie flat most of the time. The lawsuit states that in this particular case, Medtronic's bone graft was used "off label" and resulted in debilitating, painful, and uncontrolled bone growth, compressing spinal nerves.
The lawsuit states that medical device manufacturer Medtronic downplayed the risks of complications and serious side effects related to the bone graft, especially when used off-label. The suit also alleges that Medtronic "actively and illegally" promoted off-label uses. Medical device companies by law are not allowed to promote off-label uses or procedures, and physicians are required to inform patients of the off-label nature of a surgery and get their permission.
If you have suffered complications from an Infuse bone graft procedure, the Medtronic bone graft lawyers at Estey Bomberger are available to answer your questions and advise you of your legal rights. Damages obtained in a personal injury claim will vary, and may include compensation for medical expenses, lost earnings, pain and suffering, and other damages. Our experienced dangerous product attorneys are currently reviewing claims nationwide. Contact us today for more information and a free consultation.
Continue reading "Lawsuit Filed Against Infuse Bone Graft Manufacturer " »
Generic drug maker, Qualitest Pharmaceuticals, has issued a voluntary recall of multiple lots of oral contraceptives. The contraception recall is due to a packaging error, which reversed the weekly tablet order and hid the pill's expiration date. According to a statement released by Qualitest, the packaging error may cause the daily regimen of the pills to be incorrect. When taken out of sequence, the pill can be rendered ineffective and increase the risk of an unintended pregnancy. There are no immediate health risks associated with the packaging defects, however, consumers using the affected birth control pills are advised to use a non-hormonal form of contraception immediately. Qaulitest also advises consumers taking the affected product to consult a health care provider or pharmacist.
Independent studies conducted by the American Council on Exercise (ACE) and Consumer Reports have shed light on the dangers associated with the use of toning shoes like Skechers Shape-ups, Reebok EasyTone and New Balance True Balance shoes. Using electromyography to record muscle activity, researchers at ACE found no evidence to support the claims made by the makers of Skechers and other toning shoe manufacturers. The Consumer Reports study found toning shoe wearers were more likely to sustain an injury when exercising than individuals who wore regular sneakers.
Sales of Skechers Shape-Ups toning shoes, one of the latest trends in the fitness industry, have declined sharply this year. According to one estimate, Americans purchased nearly 10 million pairs of the shoes last year. However last week, Manhattan Beach, CA based Skechers reported the company lost $29.9 million in the second quarter, compared to a $40.2 million profit during the same time last year.
Skechers Shape-ups and other similar toning shoes, boots and sandals promise consumers great benefits like weight loss, better posture, and more energy. However, it is becoming increasingly evident that wearing toning shoes increases consumers' risk of sustaining a serious injury in a fall, or a stress fracture from repeated wear. Many people have reported suffering serious injuries as a result of wearing shoes, including many injuries that have required hospitalization or surgery.